Plato once noted that “creativity is a divine madness, a gift from gods.” Romantic notions of the link between mental illness and creativity still appear prominently in popular culture. But ever since scientists started formally investigating the link, there has been intense debate. Some of the most highly cited studies on the topic have been criticized on the grounds that they involve highly specialized samples with weak and inconsistent methodologies and a strong dependence on subjective and anecdotal accounts.
What has become much clearer, however, is that there is a real link between creativity and a number of traits and characteristics that are associated with mental illness. Once we leave the narrowed confines of the clinical setting and enter the larger general population, we see that mental disorders are far from categorical. Every single healthy human being lies somewhere on every psychopathology spectrum (e.g., schizophrenia, autism, mood disorders). What’s more, we each show substantial fluctuations on each of these dimensions each day, and across our lifespan.
A major issue in attempting to scientifically study the link between the various dimensions of psychopathology and creativity is the outcome measure. What should we be predicting? Because here’s the thing: Creativity also lies on a spectrum, ranging from the everyday creative cognition that allows us to generate new ideas, possibilities, and solutions to a problem, to the real-world creative achievement seen in publicly recognized domains across the arts, humanities, and sciences. Therefore, the link to psychopathology spectrum disorders may differ depending on the outcome.
Enter a new study by Darya Zabelina, David Condon, and Mark Beeman. They examined whether levels of psychopathology in a healthy non-clinical sample are associated with creative cognition and real-world creative achievement among a group of 100 participants, aged 18-30. None had been hospitalized for psychiatric or neurological reasons, and none abused alcohol or drugs.